Bruker announces the successful installation of a 1.2 GHz NMR spectrometer at the Leibniz Forschungsinstitut fur Molekulare Pharmakologie FMP in Berlin, accepted in the second quarter of 2024. This ultra-high field NMR system positions FMP among leading institutions worldwide with access to 1.2 GHz NMR, enabling breakthrough biomolecular research..Dr. Falko Busse, President of Bruker BioSpin, added: “Bruker is privileged to partner with the Leibniz Forschungsinstitut fur Molekulare Pharmakologie FMP, providing GHz-class NMR to their scientists. This can further accelerate the groundbreaking research in molecular pharmacology by FMP researchers and we are honored to contribute to such invaluable work and look forward to the scientific and medical discoveries that FMP’s research will bring to society.”
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BRKR:
